You are here

Azasite

Merck to pay $5.9 mln for misleading marketing of pink eye drug: U.S.

Yahoo/Reuters

Wed, 06/17/15 - 04:58 pm

Akorn Acquires U.S. Rights to Trio of Merck Eye Treatments

Motley Fool

Sat, 11/16/13 - 01:33 pm

Merck, Pfizer Sue Mylan to Block Proposed Copy of AzaSite

Bloomberg

Mon, 06/17/13 - 12:50 pm

2 Risks Facing Merck Today

Motley Fool

Mon, 11/12/12 - 11:26 am

Merck, InSite Vision amend payment terms of AzaSite license agreement

Yahoo/Fly on the Wall

Mon, 08/13/12 - 12:03 pm

Justice subpoenas Merck on drug marketing

Fierce Pharma

Thu, 11/10/11 - 01:19 pm

Inspire's Pink Eye Drug AzaSite Draws Generic Challenge

Motley Fool

Wed, 04/27/11 - 11:31 am

Inspire Pharmaceuticals' eye drug Azasite fails to meet key goals in midstage studies

Yahoo/AP

Mon, 03/15/10 - 11:50 am

Inspire posts smaller loss as Azasite sales rise

Yahoo/AP

Thu, 03/4/10 - 09:41 am